Echinocandin antifungal drugs.

By D. Denning. The Lancet, 2003

1,110 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. (2008, background): “The echinocandins are a novel class of semisynthetic amphiphilic lipopeptides composed of a cyclic hexapeptide core linked to a variably configured N-acyl side chain [108].”
Candida parapsilosis, an Emerging Fungal Pathogen (2008, background): “parapsilosis (1, 21, 68, 69, 109, 146, 200), particularly in clinical cases involving C.”
Aspergillus Infections in Transplant Recipients (2005, background): “area under the curve) but no change in the amount of cyclosporine in the blood (69, 270).”
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. (2016, background): “ecules is composed of a cyclic hexapeptide core linked to a variably configured N-linked fatty acyl side chain [185].”